UPC APP 14299/2024

—·EP3769722: LOW PROFILE DELIVERY SYSTEM FOR TRANSCATHETER HEART VALVE

Verfahrensdetails: Status
—
Verfahrensart
Verfahrensantrag
Kategorie
Sonstige prozessuale
Parteien: Kläger
Edwards Lifesciences Corporation
Vertreter: Jens Olsson; Siddharth Kusumakar (Powell Gilbert (Europe) LLP); Tessa Waldron (Powell Gilbert (Europe) LLP)
Beklagte
Meril Life Sciences Pvt Ltd.
Meril GmbH
SMIS INTERNATIONAL OÜ
Sormedica UAB
INTERLUX, UAB
VAB-LOGISTIK, UAB
Vertreter: Andreas von Falck (Hogan Lovells International LLP); Alexander Klicznik (Hogan Lovells International LLP)
Division: Nordic-Baltic RD
Richter: Stefan Johansson · Presiding Judge / Judge-Rapporteur
Kai Härmand · Legally Qualified Judge
Mélanie Bessaud · Legally Qualified Judge
Stefan Wilhelm · Technically Qualified Judge
Technology: Pharmaceutical & Medical
Sprache: —
Erste Entscheidung: 20. Aug. 2024

Entscheidungen

2024-08-20
Generic application
Order by Nordic-Baltic Regional Division (UPC_CFI_380/2023, 20 August 2024) dismissing Meril defendants' application to stay infringement proceedings pending EPO opposition on EP 3 769 722 (transcatheter heart valve). The court clarified that R. 295(a) RoP and Art. 33(10) UPCA allow a discretionary stay during written procedure only if a rapid EPO decision is expected; R. 118.2(b) RoP applies only in the oral procedure phase.
Rechtsfragen:Stay of proceedings (Art. 33(10) UPCA, R. 295 RoP)R. 118.2(b) RoP: limited to oral procedure phaseEPO opposition as basis for stay

Dokumente